Oruka Therapeutics, Inc.(ORKA:US)
Market Cap$3.609B
Key Metrics
Price$71.93
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$116.25M
EBITDA (TTM)-$120.76M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.52M
Total Assets$504.48M
Net Assets$483.79M
Total Debt$1.81M
Key Metrics
Price$71.93
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$116.25M
EBITDA (TTM)-$120.76M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.52M
Total Assets$504.48M
Net Assets$483.79M
Total Debt$1.81M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - |
| $36.43M | $34.43M | $34.11M | $28.43M | - | - | - | - | |
| Research and Development | $29.15M | $27.64M | $28.99M | $24.09M | - | - | - | - |
| Selling, General, and Administrative | $7.29M | $6.79M | $5.12M | $4.34M | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - |
Operating Income | -$36.43M | -$34.43M | -$34.11M | -$28.43M | - | - | - | - |
| $4.61M | $4.85M | $3.83M | $3.86M | - | - | - | - | |
| Non-Operating Interest Income | $4.61M | $4.85M | $3.83M | $3.86M | - | - | - | - |
| Non-Operating Interest Expense | - | $0 | $0 | $0 | - | - | - | - |
| Other Income/Expense | $8K | -$1K | -$4K | -$2K | - | - | - | - |
Income Before Tax | -$31.82M | -$29.58M | -$30.28M | -$24.57M | - | - | - | - |
Income Tax | - | - | - | - | - | - | - | - |
Net Income | -$31.82M | -$29.58M | -$30.28M | -$24.57M | - | - | - | - |
Minority Interests | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - |
Net Income to Common | -$31.82M | -$29.58M | -$30.28M | -$24.57M | - | - | - | - |
Shares Outstanding (Basic) | 55.31M | - | 44.2M | 42.23M | 41.68M | 15.01M | 29.4M | - |
Shares Outstanding (Diluted) | 55.31M | - | 44.2M | 42.23M | 41.82M | 15.06M | 29.4M | 29.4M |
EPS (Basic) | -$0.48 | - | -$0.55 | -$0.46 | -$0.40 | -$1.46 | -$0.76 | - |
EPS (Diluted) | -$0.48 | - | -$0.55 | -$0.46 | -$0.40 | -$1.46 | -$0.76 | - |
EBIT | -$36.43M | -$29.58M | -$30.28M | -$24.57M | - | - | - | - |
EBITDA | -$36.39M | -$29.56M | -$30.26M | -$24.56M | - | - | - | - |